These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29478267)

  • 41. A semi-parametric Bayesian approach to average bioequivalence.
    Ghosh P; Rosner GL
    Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
    Dorie V; Harada M; Carnegie NB; Hill J
    Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hierarchical Bayesian bootstrap for heterogeneous treatment effect estimation.
    Oganisian A; Mitra N; Roy JA
    Int J Biostat; 2024 May; 20(1):93-106. PubMed ID: 36584112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semiparametric Bayesian inference for optimal dynamic treatment regimes via dynamic marginal structural models.
    Rodriguez Duque D; Stephens DA; Moodie EEM; Klein MB
    Biostatistics; 2023 Jul; 24(3):708-727. PubMed ID: 35385100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Bayesian nonparametric test of significance chasing biases.
    Karabatsos G
    Res Synth Methods; 2018 Mar; 9(1):51-61. PubMed ID: 28985020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bayesian nonparametric population models: formulation and comparison with likelihood approaches.
    Wakefield J; Walker S
    J Pharmacokinet Biopharm; 1997 Apr; 25(2):235-53. PubMed ID: 9408861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Borrowing from supplemental sources to estimate causal effects from a primary data source.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2021 Oct; 40(24):5115-5130. PubMed ID: 34155662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees.
    Logan BR; Sparapani R; McCulloch RE; Laud PW
    Stat Methods Med Res; 2019 Apr; 28(4):1079-1093. PubMed ID: 29254443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semiparametric mixed-scale models using shared Bayesian forests.
    Linero AR; Sinha D; Lipsitz SR
    Biometrics; 2020 Mar; 76(1):131-144. PubMed ID: 31222729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parametric and nonparametric propensity score estimation in multilevel observational studies.
    Salditt M; Nestler S
    Stat Med; 2023 Oct; 42(23):4147-4176. PubMed ID: 37532119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bayesian estimation of the average treatment effect on the treated using inverse weighting.
    Capistrano ESM; Moodie EEM; Schmidt AM
    Stat Med; 2019 Jun; 38(13):2447-2466. PubMed ID: 30859603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of causal effects with repeatedly measured outcomes in a Bayesian framework.
    Liu K; Saarela O; Feldman BM; Pullenayegum E
    Stat Methods Med Res; 2020 Sep; 29(9):2507-2519. PubMed ID: 31994451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semiparametric Bayesian inference on skew-normal joint modeling of multivariate longitudinal and survival data.
    Tang AM; Tang NS
    Stat Med; 2015 Feb; 34(5):824-43. PubMed ID: 25404574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Bayesian nonparametric testing procedure for paired samples.
    Pereira LA; Taylor-Rodríguez D; Gutiérrez L
    Biometrics; 2020 Dec; 76(4):1133-1146. PubMed ID: 32012223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses.
    Pan J; Bunn V; Hupf B; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):613-626. PubMed ID: 35737650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes.
    Elliott MR; Raghunathan TE; Li Y
    Biostatistics; 2010 Apr; 11(2):353-72. PubMed ID: 20101045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bayesian Nonparametrics and Biostatistics: The Case of PET Imaging.
    Fall MD
    Int J Biostat; 2019 Nov; 15(2):. PubMed ID: 31774734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model feedback in Bayesian propensity score estimation.
    Zigler CM; Watts K; Yeh RW; Wang Y; Coull BA; Dominici F
    Biometrics; 2013 Mar; 69(1):263-73. PubMed ID: 23379793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide prediction using Bayesian additive regression trees.
    Waldmann P
    Genet Sel Evol; 2016 Jun; 48(1):42. PubMed ID: 27286957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Bayesian nonparametric meta-analysis model.
    Karabatsos G; Talbott E; Walker SG
    Res Synth Methods; 2015 Mar; 6(1):28-44. PubMed ID: 26035468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.